Welcome to DU! The truly grassroots left-of-center political community where regular people, not algorithms, drive the discussions and set the standards. Join the community: Create a free account Support DU (and get rid of ads!): Become a Star Member Latest Breaking News General Discussion The DU Lounge All Forums Issue Forums Culture Forums Alliance Forums Region Forums Support Forums Help & Search

BumRushDaShow

(128,478 posts)
18. The issue is patents, which involve proprietary products/processes, and whether to waive the patents
Wed May 5, 2021, 09:31 PM
May 2021

to allow others to make these products. The patents are generally 20 year things for these types of products and these pharmaceutical companies always argue that they take years to come up with this stuff and want exclusivity to market and sell it (at a premium). The "negotiations" are to deal with allowing that proprietary process to be shared with (I assume) some limit to liability of the originator if others using the process "gets it wrong", and I would assume, some agreement to appropriate compensation for giving up that exclusivity (which the DPA can provide).

I think you were arguing "cut the red tape and just make it" and it's not that easy.

**** ( ) ****

Not a moment too soon!!!!!! cloudythescribbler May 2021 #1
+1000 Gaugamela May 2021 #2
I agree with the "from the start" part Shermann May 2021 #5
The Pharma companies got billions in advance from the government, the basic research was Gaugamela May 2021 #7
Agreed, and well said! nt crickets May 2021 #23
Oh, ughh. How about coming up with something quick like very real soon? progree May 2021 #3
That's because of all the patent law BumRushDaShow May 2021 #6
None of this crap can be cut through by government edict? Like what if this was WWII and progree May 2021 #9
Well remember there was an agreement put in place for Merck to work with J&J on the Janssen vaccine BumRushDaShow May 2021 #10
" they are going to be injected (or ingested) in a human being" progree May 2021 #12
When you're talking about mRNA or virus-based vectors BumRushDaShow May 2021 #13
Quality in manufacturing and patent protection are two different issues. The patent protection progree May 2021 #14
They are related BumRushDaShow May 2021 #16
You are talking about manufacturing quality and following the recipe exactly. That has nothing to do progree May 2021 #17
The issue is patents, which involve proprietary products/processes, and whether to waive the patents BumRushDaShow May 2021 #18
"I think you were arguing 'cut the red tape and just make it' and it's not that easy." progree May 2021 #19
I really don't think it's going to take that long BumRushDaShow May 2021 #20
I saw the WTO and WHO stuff in the OP - that's what my question originally was about progree May 2021 #21
Well that might not be anything that we can control BumRushDaShow May 2021 #22
Profit above all else. That ends up in some companies having more interesting in taking lives... Lancero May 2021 #11
Precisely /nt progree May 2021 #15
It will be interesting to see if this ends up in court JohnSJ May 2021 #4
Immediate thoughts: Which patents? All of them? If Biden can persuade pharmaceuticals who used the ancianita May 2021 #8
They should tread carefully. Also, any generic Covid vaccines would be a year away... NurseJackie May 2021 #24
Covid: Germany rejects US-backed proposal to waive vaccine patents muriel_volestrangler May 2021 #25
Latest Discussions»Latest Breaking News»The Biden administration ...»Reply #18